Conjugated Estrogens Tablet, Film Coated
Product Images NDC 66993-296

This text provides information on the relative percentage change in spine bone mineral density (BMD) from baseline in subjects. It presents data in a tabular format showing the percent change for different groups, including placebo and other treatments.*

This text provides information on a prescription medication containing conjugated estrogens. It emphasizes the importance of including an "Information for the Patient" leaflet with each prescription dispensed. The medication should be stored at 20° to 25°C (68° to 77°F) with excursions allowed to 15° to 30°C (59° to 86°F). The tablets are contained in child-resistant packaging and each tablet contains 0.45 mg of conjugated estrogens in their natural form. The text mentions the manufacturer, Prasco Laboratories, located in Mason, OH, USA, and specifies that the medication is made in Canada. Dosage instructions are advised to be referred from accompanying literature.*

This is a description of a medication dispenser for tablets containing 0.625 mg of conjugated estrogens in their natural occurring form. The dispenser includes an information leaflet for the patient and should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication comes in child-resistant containers and detailed dosage information can be found in the accompanying literature. Distributed by Prasco Laboratories in Mason, Ohio, USA, and made in Canada.*

This description is about a medication that contains 1.25 mg of conjugated estrogens in tablet form. The recommended storage temperature is between 20-25°C (68-77°F) with excursions allowed to 15-30°C (59-86°F). Dispensing should be done in tight, child-resistant containers. The package includes information for the patient in a leaflet. The manufacturer is Prasco Laboratories in Mason, OH, USA, and the product is made in Canada. The usual dosage instructions are provided in accompanying literature. Medical professionals are the intended audience for this prescription medication.*

This text contains important information about a medication containing 0.3 mg of conjugated estrogens in tablet form. The prescribed storage conditions are between 20-25°C (68-77°F), with excursions allowed to 15-30°C (59-86°F). Dispensing is to be done in tightly sealed, child-resistant containers, with each prescription including an "Information for the Patient" leaflet. The product is distributed by Prasco Laboratories in Mason, OH, USA, and it is made in Canada. It also includes a National Drug Code (NDC) number for tracking. The text does not provide information about the specific medication or its purpose.*

This text is about a medication containing conjugated estrogens in tablet form. It provides information on storage conditions, dosage, distribution details, and the inclusion of a patient information leaflet. The tablets are stored within specific temperature ranges, dispensed in child-resistant containers, and a certain amount of estrogen content is mentioned per tablet. The accompanying literature should be consulted for the usual dosage. The product is distributed by Prasco Laboratories in Mason, Ohio, USA. It is manufactured in Canada and comes in a package containing 100 tablets.*